09.12.2011 • News

AkzoNobel to Issue €800 Million Bond

AkzoNobel said it intends to issue a €800 million bond with a seven year maturity, at a coupon of 4%. The announcement of the bond was well received by the market with an order book exceeding €3 billion.

AkzoNobel has simultaneously announced a tender offer to re-purchase an estimated €600 million of its previously issued bonds, specifically bonds set to mature in January 2014 (7.75%, €1 billion) and March 2015 (7.25%, €975 million).

The new bond issue and purchase of existing bonds will improve the overall debt profile of AkzoNobel, further reducing future refinancing risk and improving its maturity profile.

The buyback of company bonds will result in an accounting loss, which will be determined at the end of the tender process. However, this loss will be off-set by the significantly reduced coupon on the new seven year bond.

The new bonds will be issued by Akzo Nobel NV and will be listed on the Luxembourg Stock Exchange. Settlement is scheduled for Dec. 15, 2011, and the bonds will mature on Dec.17, 2018.

AkzoNobel said it is committed to maintaining a strong investment grade rating. Currently the company has a BBB+ rating with Standard & Poor's and a Baa1 rating with Moody's.

 

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.